Clinical Trials Browser

Multiple Myeloma, Recurrence

Multiple Myeloma, Recurrence

Chromosome 17 deletion, Recurrence, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

Multiple Myeloma, Recurrence

Multiple Myeloma, Recurrence

Lymphoma, Follicular, Recurrence, Lymphoma, B-Cell, Marginal Zone

Unilateral Breast Neoplasms, Breast Neoplasms, Recurrence

Recurrence, Endometrial Neoplasms

Burkitt Lymphoma, Recurrence, Lymphoma, Large B-Cell, Diffuse, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Neoplasm Metastasis, Recurrence

Disease, Recurrence, Leukemia, Myeloid, Acute

Immunoblastic Lymphadenopathy, Lymphoma, Recurrence, Lymphoma, T-Cell, Peripheral

Carcinoma, Renal Cell, Kidney Neoplasms, Recurrence

Urinary Bladder Neoplasms, Recurrence

Biliary Tract Neoplasms, Gallbladder Neoplasms, Recurrence

Nasopharyngeal Carcinoma, Recurrence

Recurrence, Lymphoma, Large B-Cell, Diffuse

Melanoma, Neoplasms, Recurrence

Multiple Myeloma, Recurrence

Recurrence, Leukemia, Myeloid, Acute

Ovarian Neoplasms, Recurrence

Recurrence, Thyroid Neoplasms

Recurrence, Colorectal Neoplasms

Nasopharyngeal Carcinoma, Recurrence

Esophageal Neoplasms, Recurrence

Clinical Trials

SUCCESSOR-1

A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Participants With Relapsed or Refractory Multiple Myeloma

ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

A Multicenter, Randomized, Open-label, Parallel-group, Controlled, Superiority Phase III Clinical Study Comparing the Efficacy and Safety of F182112 Versus Standard of Care in Patients With Relapsed or Refractory Multiple Myeloma

OLYMPIA-5

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

RAINFOL-03

Study of Out of Specification for Tisagenlecleucel

FIERCE-HN

IMPACT-AML

TERZO

LUTEON

EVER

AB02

Magic-C002

A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma

PRIME

FREEDOM

Selinexor in Combination With HAD or CAG Rregimens in Relapsed or Refractory Acute Myeloid Leukemia

CHIPRO

A Prospective, Open-label, Multicenter, Randomized Controlled Phase III Study of Prophylactic Central Neck Dissection in Low-risk Papillary Thyroid Cancer

COLLISION RELAPSE Trial

Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma

Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients